Skip to content
Search

Latest Stories

Giving as Medicine for the Soul

According to Dr. Froswa Booker-Drew, giving is about more than just money—it’s about offering your time, your talent, or whatever is meaningful to you.

Akarawut Lohacharoenvanich
A woman in a sleeveless green dress stands at a clear podium, speaking into a handheld microphone. She has long, dark hair and wears a pink ribbon pin, symbolizing breast cancer awareness. A projection screen behind her shows a live feed of her speech.

Breast cancer survivor Karla Mingo shares her journey to inspire women and emphasize the life-saving importance of early detection.

A smiling young woman with braided hair, wearing a light-colored blazer and watch, holding a grey coffee mug with both hands. She is sitting in a modern, well-lit office space with green plants in the background.
Black women deserve to practice self-care, even while navigating the demands of the workplace.
istock - PeopleImages
Research

Botox for Migraines: A Promising Solution Backed by Science

Botox, a neurotoxin derived from the bacterium Clostridium botulinum, is widely known for its cosmetic applications. However, it has also gained recognition as an effective treatment for chronic migraines. Approved by the FDA for this use in 2010, Botox has since provided relief for many who suffer from this debilitating condition. This article delves into how Botox works to alleviate migraines and examines the research behind its efficacy.

How Botox Works for Migraines

Botox works by blocking the release of neurotransmitters that carry pain signals from the brain. When injected into specific areas around the head and neck, Botox enters nerve endings and prevents the release of chemicals involved in pain transmission, such as calcitonin gene-related peptide (CGRP). This disruption of pain signaling pathways helps reduce the frequency and severity of migraine attacks .


The standard Botox treatment for chronic migraines involves a series of injections at specific points around the forehead, temples, back of the head, neck, and upper back. A typical treatment session consists of 31 injections with a total of 155 units of Botox. The treatment is usually repeated every 12 weeks .

Research on Botox for Migraines

Pivotal Trials and FDA Approval

The efficacy of Botox for migraines was first established in two pivotal Phase 3 clinical trials known as PREEMPT 1 and PREEMPT 2 (Phase 3 Research Evaluating Migraine Prophylaxis Therapy). These trials, conducted in 2009, included 1,384 adult participants who experienced chronic migraines (defined as having 15 or more headache days per month, with at least 8 being migraine days).

The PREEMPT trials demonstrated that Botox significantly reduced the frequency of headache days compared to placebo. Participants receiving Botox experienced an average reduction of 7.8 to 9.2 headache days per month, while those receiving a placebo saw a reduction of 6.4 to 6.9 days. Additionally, the Botox group reported improvements in headache-related quality of life and reductions in the severity and duration of headaches .

Long-term Efficacy and Safety

Further studies have supported the long-term efficacy and safety of Botox for chronic migraine treatment. A 2014 study by Blumenfeld et al. followed patients over a 56-week period and confirmed sustained reductions in headache frequency and severity with repeated Botox treatments. The study also noted that patients experienced improvements in functioning and overall quality of life .

A 2018 meta-analysis by Simpson et al. reviewed 17 randomized controlled trials and concluded that Botox is an effective prophylactic treatment for chronic migraines, with a favorable safety profile. The most common side effects reported were mild to moderate and included neck pain, muscle weakness, and injection site pain .

Mechanisms of Action: Beyond Pain Blockade

While the primary mechanism of Botox in migraine treatment is the blockade of pain neurotransmitters, research suggests additional benefits. Botox may also modulate peripheral and central sensitization, processes involved in the development and maintenance of chronic pain. By reducing peripheral sensitization, Botox can prevent the escalation of pain signals, while its effects on central sensitization help alleviate the heightened pain response characteristic of chronic migraines .

Patient Experience and Considerations

For patients considering Botox treatment for migraines, it is important to consult with a healthcare provider to determine if they are suitable candidates. Botox is typically recommended for individuals with chronic migraines who have not responded adequately to other preventive treatments. It is not approved for episodic migraines (less than 15 headache days per month).

Most patients begin to notice improvements within 2 to 3 weeks after their first treatment, with optimal results usually observed after the second or third session. Regular follow-up treatments are necessary to maintain the benefits, as the effects of Botox are temporary and typically last around 12 weeks .

Botox has emerged as a valuable tool in the management of chronic migraines, offering relief for many patients who struggle with this challenging condition. Through its ability to block pain signals and modulate sensitization processes, Botox can significantly reduce the frequency and severity of migraine attacks. Ongoing research continues to shed light on its mechanisms and long-term benefits, providing hope for those affected by chronic migraines.

References

  1. Silberstein, S. D., & Lipton, R. B. (2013). Chronic Migraine: Classification, Differential Diagnosis, and Epidemiology. Headache: The Journal of Head and Face Pain, 53(1), 77-83.
  2. Dodick, D. W., et al. (2010). OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program. Headache, 50(6), 921-936.
  3. Blumenfeld, A. M., et al. (2014). Long-Term Study of the Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine: COMPEL Study. Neurology, 83(11), 921-928.
  4. Simpson, D. M., et al. (2018). Botulinum Toxin Type A for the Treatment of Chronic Migraine: A Meta-Analysis. Journal of the American Medical Association, 319(16), 1742-1753.
  5. Aurora, S. K., & Charles, A. (2011). Botulinum Toxin Type A Prophylactic Treatment of Chronic Migraine: A Systematic Review. Current Pain and Headache Reports, 15(4), 287-295.
  6. Blumenfeld, A. M. (2010). OnabotulinumtoxinA in the Treatment of Chronic Migraine: Review of PREEMPT Phase 3 Trials. Journal of Pain Research, 3, 159-169.
  7. Jackson, J. L., Kuriyama, A., & Hayashino, Y. (2012). Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults: A Meta-Analysis. Journal of the American Medical Association, 307(16), 1736-1745.

More Stories

Cord Blood Awareness Month: What It Is and Why It Matters
New England Cord Blood Bank

Cord Blood Awareness Month: What It Is and Why It Matters

Every July, Cord Blood Awareness Month brings attention to a powerful, life-saving resource that many parents may not even realize they have access to: cord blood. This observance promotes education about what cord blood is, its potential uses in medicine, and the importance of banking or donating it for future treatment options. While often discarded after birth, cord blood contains stem cells with the power to treat over 80 life-threatening diseases, making it an invaluable asset in modern medicine.

What Is Cord Blood?

Cord blood is the blood remaining in the umbilical cord and placenta after childbirth. This blood is rich in hematopoietic stem cells, the same type of cells found in bone marrow. These stem cells have the ability to develop into various types of blood and immune system cells, which is why they are often used in stem cell transplants for treating blood-related conditions.

Keep ReadingShow less
Oncoplastic Surgery Is Redefining Wholeness for Black Breast Cancer Survivors

Ronda Henry-Tillman, M.D., a surgical oncologist specializing in breast cancer, is dedicated to ensuring that all women have access to the best possible options for their breast surgery.

Oncoplastic Surgery Is Redefining Wholeness for Black Breast Cancer Survivors

For many breast cancer patients, surviving the disease is just one part of the journey. The path forward often includes physical healing, emotional restoration, and reclaiming one’s sense of self. That’s where oncoplastic surgery is changing the landscape—offering women not only life-saving procedures but also renewed confidence and dignity.

This innovative approach blends oncology (cancer surgery) with plastic and reconstructive techniques, allowing surgeons to remove tumors while reshaping the breast for a more natural appearance. The result? A holistic healing process that honors both survival and self-image.

Keep ReadingShow less
Wellness Through a Cultural Lens: What Traditional Healing Can Teach Us

Wellness Through a Cultural Lens: What Traditional Healing Can Teach Us

The idea of wellness has taken center stage in today's world, but its definition changes from one culture to another. Modern health trends push workout plans, eating strategies, and self-care habits, while old-school healing methods give a wider more complete view of health and wellness. To grasp what health and wellness mean, we need to look past common beliefs and tap into the knowledge found in age-old cultural practices.

Various ancient healing methods see wellness as a living harmony among the mind, body, and spirit tied to nature and society. Worldwide Native medicine Ayurveda, Traditional Chinese Medicine (TCM), and other healing schools of thought offer a treasure trove of wisdom that tests and enhances modern wellness concepts. Looking into these customs can give useful health and wellness advice helping people create a deeper and more significant way to care for themselves.

Keep ReadingShow less
Silent Surge: As Diseases Spread, CDC Quiet on Public Warnings
Photo by CDC on Unsplash

Silent Surge: As Diseases Spread, CDC Quiet on Public Warnings

In recent months, a concerning pattern has emerged in the U.S. public health landscape: while infectious diseases are quietly on the rise, the Centers for Disease Control and Prevention has been notably more restrained in its public communications compared to earlier in the COVID-19 pandemic. From respiratory illnesses to measles outbreaks, the spread of disease is increasing—but without the loud, consistent messaging that once guided public behavior and preparedness.

This shift raises questions about public risk, trust in institutions, and the evolving role of the CDC in post-pandemic America.

Keep ReadingShow less
A Deadly E. coli Outbreak Spread Across 15 States — and the FDA Kept Us in the Dark
File:FDA Sign & Bldg 21 at Entrance (5204602349).jpg - Wikimedia ...

A Deadly E. coli Outbreak Spread Across 15 States — and the FDA Kept Us in the Dark

As Americans continue to trust that the food on their plates is safe, troubling revelations suggest that the U.S. Food and Drug Administration (FDA) may be keeping critical information under wraps. Multiple E. coli outbreaks have sickened dozens—some severely—while the agency has withheld key details such as food sources, affected regions, and even the names of implicated suppliers. In a system built on public trust and transparency, these omissions raise urgent questions: Why is the FDA staying silent, and what are the consequences for consumers?

Delayed Disclosures and Withheld Information

In December 2024, the FDA acknowledged an outbreak of E. coli O157:H7 that affected at least 67 people. Despite initiating traceback efforts, the agency failed to disclose key details such as where the cases occurred or which foods were being investigated.

Keep ReadingShow less
×